In an effort to encourage entrepreneurial growth in San Diego, CyberTECH created its Entrepreneur in Residence program (EIR) in early 2016. Because of the success of the initial cohort of businesses, CyberTECH opted to welcome a second cohort of business during the latter half of the year.

Each business represents a new and emerging approach to business by utilizing technology to spur further growth. The businesses have access to low-cost office space inside the First and Fir office along with other Member benefits like high-speed internet, printing, event space, and networking opportunities.

Moreover, these business owners have access to a rigorous regime of one-on-one coaching with industry experts and business professionals. The primary goal of these coaching sessions is to steer each business towards stability and growth. Stability becomes a key factor in the long-term viability for small business owners. While many small businesses experience short bursts of growth due to unique opportunities or market conditions, many of those same businesses fall short of creating a sustainable financial future. The EIR program intends to help those business owners avoid those pitfalls with coaching and mentoring.

Coaches include David Titus (Senior Vice President of Cooley LLP), Ignacio Yanez, Don W Larson for tech guidance, and Susan Rust (FlashPoint Marketing) for marketing support.

The 2016 EIR Cohort 200 group represents a range of industries including cyber-security, drone technology, sports media, and insurance. All the business share an enthusiasm for technology and an entrepreneurial spirit. CyberTECH will officially welcome the second Cohort Class of 2016 at 3rd Annual Good Neighbor fundraiser on Thursday November 10th from 5:00 PM to 9:00 PM.

Visit the Entrepreneur in Residence Program for more details

Launching tech startup? “Don’t Panic” to the rescue

Ever wonder what sorts of issues you may encounter as a creator or entrepreneur? Or when you might want to reach out to a real-life lawyer?

That’s what Don’t Panic:) A Legal Guide (in plain English) for Small Businesses and Creative Professionals is all about.

Published by New Media Rights, with offices at iHive @ NEST in San Diego, this recently-published book is designed to help new-business owners of all kinds.

Don’t Panic:) will prepare you to deal with a wide range of legal issues you’re likely to encounter as a startup creator or tech entrepreneur.

The book’s authors are Art Neill, executive director of New Media Rights; and Teri Karobonik, former staff attorney at the non-profit agency.

Click here to buy the book on Amazon

Electronic version – $9.99 | Paperback – $14.99

Founded in 2013, SD3D Printing provides a one-stop shop for innovative 3D printing, scanning and design services in San Diego. Here’s an investment update from co-founder David Feeney:

“We were recently accepted into the Tech WildCatters (TW) accelerator program in Dallas, Texas. The process includes a $30,000 staged investment to help get us through what they call ‘The Gauntlet,’ which is their version of internally guided due diligence.

“The Gauntlet has five levels through which a startup progresses — Discovery, Build, Launch, Grow and Scale.

“Once a startup reaches Level 5, TW syndicates an investor dinner with the goal of opening and closing the startup’s seed round during that dinner. They lead the round with $100,000 of their own funding. Then the startup pitches to the group to bring in additional angels to the deal.
“Previously, every company that has reached Level 5 of the TW program has successfully oversubscribed their desired seed round during the syndicated investor dinner.

“We expect to reach Level 5 by mid-December. Bennett Berger, our co-founder and president, will be relocating to Dallas to ensure the process runs smoothly and remains on schedule.

“We will also be installing our second 3D printing kiosk at the TW headquarters in downtown Dallas. Our first was installed at iHive last month.”

SOURCE: SD3D Printing

Webroot buys Cyberflow Analytics, to expand in San Diego

Webroot, the market leader in next-generation endpoint security and threat intelligence, has announced it has acquired the assets of CyberFlow Analytics, an innovator in applying data science to network anomaly detection.

This acquisition enhances Webroot’s ability to address the explosion of internet-connected devices and an increasingly complex threat landscape. The company plans to expand its operations in San Diego.

Adding the FlowScape network behavioral analytics solution extends Webroot’s leadership in machine learning-based cybersecurity to the network layer.

As malware is now overwhelmingly polymorphic and advanced persistent threats (APTs) mask their activities within everyday network noise, SaaS-based FlowScape adversarial analytics and unsupervised machine learning enables Webroot to further reduce time to classify and address threats.

“Today, one of the only things attackers can’t find out about your network is what’s normal,” said Dick Williams, Webroot CEO. “This solution can identify and alert on potentially malicious activity that deviates from normal traffic in milliseconds.”

SOURCE: PRNEWSWIRE,
Sept. 21, 2016

CyberTECH member QuiO (kwee-oh), a San Diego-based digital healthcare company developing smart injection devices and connected cloud-based software for the clinical trial and chronic disease market, announced the closing of a $1.05 million seed round.

The round was led by undisclosed investors with expertise in the health insurance, pharmaceutical and clinical research industries.

Medication non-adherence poses significant clinical and economic problems to healthcare systems globally, especially involving chronic disease patients who must self-inject at home.

The internet of medical things (IoMT) has shown success in addressing the issue, including inhaler sensors, connected pill bottles, and other adherence monitoring devices.

However, patients taking injectable therapies do not have access to such tools today, and average adherence rates can be as low as 50%.  Poor adherence to injectable therapies results in over $14 billion in avoidable medical costs and $22 billion in lost pharmaceutical revenue each year in the United States alone.

“With over 15 million Americans prescribed an injectable therapy today, we see a large and growing need for a comprehensive drug delivery and adherence monitoring solution,” said Alex Dahmani, co-founder and CEO of QuiO.

“Injectable therapies, including biologics and biosimilars, represent the future of medicine, making up nearly half of the pharmaceutical pipeline,” said Dahmani. “These are amazing therapies, and our technology is designed to help them reach their full potential.  We may even help move cancer therapies out of the clinic, enabling patients to safely treat themselves at home.”

QuiO is developing the first real-time adherence monitoring solution for injectable therapies.  The solution is powered by a fully connected drug delivery device platform.

SOURCE: www.quio.com